2m 2m 2m 2m 2m 2m 2m
CABALETTA BIO (CABA)
NASDAQ
$1.48+$0.03 (+2.07%)
Price as of Nov 11, 2026 7:46 PM EST- $312.8MMarket Cap
- -41.30%1-Year Change
- BiotechnologyIndustry
CABALETTA BIO (CABA)
$1.48+$0.03 (+2.07%)
CABA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.45 | ||
Change | -$0.05 (-3.33%) | ||
Open | $1.51 | ||
High | $1.54 | ||
Low | $1.41 | ||
Previous Close | $1.50 | ||
Volume | 3,601,312 | ||
30-Day Average Volume | 5,002,800 | ||
1-Week Change | 2.11% | ||
1-Month Change | -24.87% | ||
1-Year Change | -41.30% | ||
3-Year Change | -91.89% | ||
5-Year Change | -88.68% | ||
Fundamentals | |||
Shares Outstanding | 215.7M | ||
Total Assets | $336.5M | ||
Market Cap | $312.8M | ||
Enterprise Value | $13.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.1M | ||
Free Cash Flow | -$42.9M | ||
EBIT | -$52.5M | ||
EBITDA | -$52.2M | ||
Net Working Capital | $262.5M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue